Agomab Therapeutics shareholders vote on director nominees Marino Garcia, Naimish Patel at Sept. 11 meeting
AGMB•Shareholders to vote on board nominees
Agomab Therapeutics shareholders will vote Sept. 11, 2026 on adding two non-executive directors to the board.
- Board-backed slate: Marino Garcia and Naimish Patel
- Each would serve a four-year term ending after the 2030 annual meeting
- The appointments follow a recommendation from the remuneration, nomination, and corporate governance committee
